Plus Therapeutics, Inc.
- PSTV
- NASDAQ
- Biotechnology
- Cancer Therapeutics (Oncology)
- Nanoparticle Drug Delivery
- Radiopharmaceuticals (RNL)
$3.87
Today −3.25%Quote Jul 31, 2026, 08:00 PM UTC
−1.23%over the last month
Max drawdown −17.8%From 1-month high −6.5%3 months −36.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$26.2M
Approximate share count
Next earnings
—
Data unavailable
Analyst target
$25.00
+546.0% from here
Floor
$3.77
2.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PSTVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
28
Founded
1996